rs13376101: 4q25 PITX2 Locus and Atrial Fibrillation Risk
The genetic variant rs13376101 is an intergenic single nucleotide polymorphism situated on chromosome 4q25 near the PITX2 gene. Research from genome-wide association studies links common variants in this chromosomal region to an increased susceptibility to atrial fibrillation and atrial flutter. However, carrying an associated allele is not a medical diagnosis, as arrhythmias arise from a complex interplay of genetic predisposition, lifestyle factors, and cardiovascular health.
What each genotype means
Baseline atrial fibrillation risk
This genotype represents the common, non-risk version of this variant. Research indicates that individuals with this profile do not carry the specific genetic signal near the PITX2 locus associated with increased susceptibility to atrial fibrillation.
This is the most common genotype in most global populations, carried by the majority of individuals.
Slightly increased risk profile
Carrying one copy of the risk-associated allele is statistically linked to a modest increase in the likelihood of developing atrial fibrillation or flutter. This association is based on population-level studies near the 4q25 locus, though individual risk is influenced by many other genetic and lifestyle factors.
Carried by approximately 25-35% of people of European ancestry, with frequencies varying significantly across other global populations.
Elevated atrial fibrillation risk
Carrying two copies of this variant is associated with a higher statistical risk of atrial fibrillation compared to those without the variant. Because this is a complex trait, this result should not be viewed as a diagnosis; please discuss your overall cardiovascular health and any symptoms with your clinician.
Carried by roughly 1 in 25 to 1 in 40 people of European ancestry; it is less common in many other populations.
Genomic Location and the 4q25 Region
The single nucleotide polymorphism rs13376101 is located on the long arm of chromosome 4 in the 4q25 chromosomal region. It is classified as an intergenic variant, meaning it does not fall directly within the protein-coding sequence of an annotated gene. Instead, it resides in a non-coding chromosomal neighborhood that has drawn substantial attention in human genetics. The 4q25 region contains several independent clusters of genetic variation strongly linked to cardiac electrophysiology. Non-coding variants in this area are widely hypothesized to reside within distant regulatory elements, such as tissue-specific enhancers or chromatin loop anchors, that influence the expression of nearby developmental and structural genes rather than altering protein structure directly.
The Biological Role of Nearby PITX2
The most prominent gene in proximity to rs13376101 is PITX2, which encodes the paired-like homeodomain transcription factor 2. PITX2 plays an indispensable role during embryonic development, specifically in establishing left-right anatomical asymmetry and guiding the structural and electrical formation of the pulmonary veins and the left atrium. In the mature heart, PITX2 coordinates the expression of key ion channel subunits, calcium-handling proteins, and intercalated disc components that maintain rhythmic cardiac conduction. Experimental models demonstrate that impaired or altered PITX2 expression creates a biological substrate vulnerable to ectopic electrical firing and abnormal conduction pathways, linking this locus directly to the mechanisms underlying atrial arrhythmias.
Research Findings and Evidence Strength
Extensive genome-wide association studies (GWAS) have repeatedly established chromosome 4q25 as the strongest and most consistently replicated genetic locus associated with typical and early-onset atrial fibrillation. Variants across this broad block, including rs13376101, demonstrate statistical significance that meets stringent genome-wide thresholds in population studies. However, the catalog classifies direct functional evidence for rs13376101 itself as limited because it is an intergenic marker. In many cases, it acts as a tag or proxy variant in linkage disequilibrium with other regulatory signals across 4q25. Furthermore, while statistical risk associations are clear, the precise effect sizes can vary considerably depending on ancestry, background cardiovascular comorbidities, and study design.
Population Distribution and Genetic Context
Allele frequencies for rs13376101 exhibit notable variation across diverse global ancestral backgrounds. In populations of European ancestry, the minor allele frequency typically ranges between 0.15 and 0.20, meaning that roughly 15% to 20% of chromosomes carry the variant. In other global populations, the frequency may fluctuate or exist within distinct linkage disequilibrium structures alongside alternative lead variants in the 4q25 region. Because the architectural landscape of non-coding regulatory DNA differs across ancestries, the presence of a specific single nucleotide polymorphism may track differently with causal regulatory elements depending on an individual's genetic heritage, underscoring the importance of multi-ancestry genomic cohorts.
Clinical Limitations and What You Can Do
Genetic data regarding rs13376101 is strictly educational and cannot be used to diagnose, predict with certainty, or rule out atrial fibrillation or atrial flutter. Common variants in 4q25 confer modest statistical alterations in relative risk, not definitive clinical outcomes; many individuals with risk alleles never experience an arrhythmia, whereas many who develop atrial fibrillation carry no known risk variants. Patients should never alter prescription medications or cardiac therapy regimens based on consumer genetic readouts. For any questions regarding medication selection, antiarrhythmic therapies, or drug dosing, consult a qualified physician or clinical pharmacist. Modifiable cardiovascular risk factors—such as blood pressure, alcohol consumption, sleep apnea, and aerobic fitness—remain primary targets for maintaining heart health.
How common is this variant?
The minor allele frequency for rs13376101 is approximately 0.15 to 0.20 in populations of European ancestry, with variant frequencies and linkage disequilibrium patterns varying across other continental populations.
Frequently asked questions
What is rs13376101?
rs13376101 is a common single nucleotide polymorphism located in an intergenic region on chromosome 4q25. It sits near the PITX2 gene, an essential regulator of heart development and atrial rhythm. Genetic studies use it as a marker to investigate inherited susceptibility to cardiac arrhythmias.
Does having the rs13376101 risk allele mean I will get atrial fibrillation?
No, carrying a risk allele does not mean you will develop atrial fibrillation. The variant confers only a modest statistical shift in relative risk across large populations rather than a deterministic outcome. Most individuals who carry these variants maintain normal cardiac function throughout life.
Why is the 4q25 region near PITX2 so important in cardiac genetics?
Chromosome 4q25 is the most consistently replicated genetic locus linked to atrial fibrillation in genome-wide association studies. The nearby PITX2 gene orchestrates the formation and electrical stability of the left atrium and pulmonary veins. Disruptions in the regulation of PITX2 can predispose cardiac tissue to electrical instability.
Can rs13376101 testing guide my heart medications?
No, commercial or direct-to-consumer testing of rs13376101 is not approved for selecting or adjusting medications. While researchers study how 4q25 variants influence treatment outcomes, there are no established clinical guidelines recommending medication changes based on this variant. Always discuss medication regimens and dosing with a licensed physician or pharmacist.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs13376101?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in PITX2
This non-coding variant on chromosome 4q25 near PITX2 is a strongly replicated genetic risk factor for atrial fibrillation and may influence patient response to anti-arrhythmic therapy.
This variant is associated with PITX2-related eye abnormalities, which can affect ocular development.